Emerging evidence for the use of atypical antipsychotics in borderline personality disorder

  • Grootens K
  • Verkes R
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Background: The availability of new atypical antipsychotics provides new opportunities for the treatment of borderline personality disorder (BPD). Methods: Original papers on this topic were sought. Our study reviewed and discussed 14 papers. Results: 2 RCTs, 4 non-controlled open-label studies and 8 case reports. The patient populations studied were highly diverse and the dropout rate after a long follow-up period was high. All of the articles reported positive effects of olanzapine, clozapine, quetiapine and risperidone. Conclusion: BPD patients with psychotic-like, impulsive or suicidal symptoms might benefit from atypical antipsychotics. Since the methodological quality of the reviewed articles is poor, further randomised placebo-controlled studies with longer follow-ups are needed before any firm conclusions can be drawn.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • K.P. Grootens

  • R.J. Verkes

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free